Qiu Sun

2.3k total citations · 2 hit papers
60 papers, 1.6k citations indexed

About

Qiu Sun is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Qiu Sun has authored 60 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 15 papers in Organic Chemistry and 13 papers in Oncology. Recurrent topics in Qiu Sun's work include Protein Degradation and Inhibitors (6 papers), Melanoma and MAPK Pathways (5 papers) and Synthesis and biological activity (4 papers). Qiu Sun is often cited by papers focused on Protein Degradation and Inhibitors (6 papers), Melanoma and MAPK Pathways (5 papers) and Synthesis and biological activity (4 papers). Qiu Sun collaborates with scholars based in China, Germany and United States. Qiu Sun's co-authors include Huan Xiao, Burkhard König, Lingling Ma, Mengyuan Huang, Lili Tian, Guan Wang, Feng Zhu, Liang Ouyang, Yuquan Wei and Gao Tu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Angewandte Chemie International Edition.

In The Last Decade

Qiu Sun

54 papers receiving 1.6k citations

Hit Papers

Therapeutic target database update 2018: enriched resourc... 2017 2026 2020 2023 2017 2021 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics
    2017 418 citations Yinghong Li, Peng Zhang et al. Nucleic Acids Research profile →
  2. Clinically-Relevant ABC Transporter for Anti-Cancer Drug Resistance
    2021 178 citations Huan Xiao, Qiu Sun et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qiu Sun China 18 884 261 245 234 162 60 1.6k
Yew Mun Lee Singapore 20 825 0.9× 197 0.8× 237 1.0× 211 0.9× 164 1.0× 33 1.7k
Xiangqian Kong China 24 1.2k 1.3× 195 0.7× 257 1.0× 176 0.8× 131 0.8× 77 1.9k
Suvankar Banerjee India 15 711 0.8× 354 1.4× 322 1.3× 361 1.5× 145 0.9× 60 1.4k
Tuomo Laitinen Finland 26 970 1.1× 150 0.6× 354 1.4× 193 0.8× 115 0.7× 90 1.8k
Dima A. Sabbah Jordan 21 751 0.8× 275 1.1× 371 1.5× 169 0.7× 151 0.9× 83 1.5k
Adam Yasgar United States 25 1.4k 1.6× 286 1.1× 271 1.1× 540 2.3× 144 0.9× 51 2.4k
Tatu Pantsar Finland 13 947 1.1× 250 1.0× 204 0.8× 401 1.7× 66 0.4× 28 1.6k
Pankaj Kumar Singh India 30 743 0.8× 273 1.0× 772 3.2× 213 0.9× 122 0.8× 127 2.3k
Onat Kadioglu Germany 26 1.1k 1.2× 486 1.9× 175 0.7× 216 0.9× 139 0.9× 63 2.0k
Tove Tuntland United States 25 732 0.8× 214 0.8× 482 2.0× 126 0.5× 151 0.9× 39 1.7k

Countries citing papers authored by Qiu Sun

Since Specialization
Citations

This map shows the geographic impact of Qiu Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiu Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiu Sun more than expected).

Fields of papers citing papers by Qiu Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiu Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiu Sun. The network helps show where Qiu Sun may publish in the future.

Co-authorship network of co-authors of Qiu Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Qiu Sun. A scholar is included among the top collaborators of Qiu Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiu Sun. Qiu Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Ailing, Xiao Li, Yifan Zhu, et al.. (2025). Discovery of 3-indolylbenzoquinone derivatives with therapeutic potential for breast cancer. Bioorganic & Medicinal Chemistry. 120. 118094–118094. 2 indexed citations
2.
3.
Sun, Qiu, Yan Deng, Yuying Feng, et al.. (2025). Multiscale biased chemical space remodeling for developing APLNR agonists with anti-HFpEF efficacy. Proceedings of the National Academy of Sciences. 122(18). e2423432122–e2423432122.
4.
5.
Xiao, Huan, Shuai Wen, Chengyong Wu, et al.. (2025). A first-in-class selective inhibitor of ERK1/2 and ERK5 overcomes drug resistance with a single-molecule strategy. Signal Transduction and Targeted Therapy. 10(1). 70–70. 3 indexed citations
6.
Zhao, Min, et al.. (2024). Protein tyrosine phosphatases: emerging role in cancer therapy resistance. Cancer Communications. 44(6). 637–653. 4 indexed citations
7.
8.
Li, Shenglin, Xinmei Yang, Ting Lu, et al.. (2024). Extracellular volume fraction can predict the treatment response and survival outcome of colorectal cancer liver metastases. European Journal of Radiology. 175. 111444–111444. 2 indexed citations
9.
Xiao, Huan, et al.. (2023). Ras superfamily GTPase activating proteins in cancer: Potential therapeutic targets?. European Journal of Medicinal Chemistry. 248. 115104–115104. 5 indexed citations
10.
Zhong, Xue, Qiu Zhong, Shilong Zheng, et al.. (2023). Discovery of berberine analogs as potent and highly selective p300/CBP HAT inhibitors. Bioorganic Chemistry. 138. 106597–106597. 7 indexed citations
11.
Li, Yang, et al.. (2023). Development of covalent inhibitors: Principle, design, and application in cancer. SHILAP Revista de lepidopterología. 2(4). 32 indexed citations
12.
Gao, Yan, Kaiyu Wang, Jin Zhang, et al.. (2023). Multifunctional nanoparticle for cancer therapy. SHILAP Revista de lepidopterología. 4(1). e187–e187. 48 indexed citations
13.
Li, Yang, et al.. (2023). Small molecules targeting protein–protein interactions for cancer therapy. Acta Pharmaceutica Sinica B. 13(10). 4060–4088. 36 indexed citations
14.
Hong, Weiqi, H. J. Yang, Ziqi Zhang, et al.. (2023). Cisplatin‐induced oxPAPC release enhances MDSCs infiltration into LL2 tumour tissues through MCP‐1/CCL2 and LTB4/LTB4R pathways. Cell Proliferation. 57(4). e13570–e13570. 6 indexed citations
15.
Sun, Qiu, et al.. (2022). ncRNA-Mediated High Expression of LPCAT1 Correlates with Poor Prognosis and Tumor Immune Infiltration of Liver Hepatocellular Carcinoma. Journal of Immunology Research. 2022. 1–12. 4 indexed citations
16.
Sun, Qiu, Mengyuan Huang, & Yuquan Wei. (2020). Diversity of the reaction mechanisms of SAM-dependent enzymes. Acta Pharmaceutica Sinica B. 11(3). 632–650. 68 indexed citations
17.
Li, Yinghong, Peng Zhang, Jing Tang, et al.. (2017). Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics. Nucleic Acids Research. 46(D1). D1121–D1127. 418 indexed citations breakdown →
18.
Sun, Qiu, et al.. (2015). Flavonoid derivatives as selective ABCC1 modulators: Synthesis and functional characterization. European Journal of Medicinal Chemistry. 109. 124–133. 34 indexed citations
19.
20.
Sun, Qiu, et al.. (2015). A triphenylphosphine mediated photo-rearrangement and methanol addition of aryl chalcones to 1-propanones. Photochemical & Photobiological Sciences. 14(5). 948–952. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yew Mun Lee Breakdown of academic impact, for papers by Xiangqian Kong Breakdown of academic impact, for papers by Suvankar Banerjee Breakdown of academic impact, for papers by Tuomo Laitinen Breakdown of academic impact, for papers by Dima A. Sabbah Breakdown of academic impact, for papers by Adam Yasgar Breakdown of academic impact, for papers by Tatu Pantsar Breakdown of academic impact, for papers by Pankaj Kumar Singh Breakdown of academic impact, for papers by Onat Kadioglu Breakdown of academic impact, for papers by Tove Tuntland
Rankless by CCL
2026